Bibliography | CPRD

Research using CPRD data has informed drug safety guidance and clinical practice and resulted in over 2,700 peer-reviewed publications. The CPRD bibliography is updated on a monthly basis (last updated 6 April 2021) and papers are listed below and in the PDF below.

If you have published papers using CPRD data which are not included in this list, please contact us at enquiries@cprd.com so that we can update the bibliography.

Download:

CPRD bibliography

CPRD bibliography

(PDF, 5MB, 226 pages)

This work uses data provided by patients and collected by the NHS as part of their care and support. CPRD encourages researchers to use this citation in all publications using CPRD data. Find out more about acknowledging the use of patient data at the Understanding Patient Data website.

Export 19 results:

Filters: Author is Tomlinson, L. A. [Clear All Filters]

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

A

K. E. Mansfield, Douglas, I. J., Nitsch, D., Thomas, S. L., Smeeth, L., and Tomlinson, L. A., “Acute kidney injury and infections in patients taking antihypertensive drugs: a self-controlled case series analysis”, Clin Epidemiol, vol. 10, pp. 187-202, 2018.

M. Schmidt, Mansfield, K. E., Bhaskaran, K., Nitsch, D., Sorensen, H. T., Smeeth, L., and Tomlinson, L. A., “Adherence to guidelines for creatinine and potassium monitoring and discontinuation following renin-angiotensin system blockade: a UK general practice-based cohort study”, BMJ Open, vol. 7, p. e012818, 2017.

B

S. J. Sinnott, Mansfield, K. E., Schmidt, M., Bhaskaran, K., Smeeth, L., Nitsch, D., and Tomlinson, L. A., “Biochemical monitoring after initiation of aldosterone antagonist therapy in users of renin-angiotensin system blockers: a UK primary care cohort study”, BMJ Open, vol. 7, p. e018153, 2017.

C

M. Iwagami, Caplin, B., Smeeth, L., Tomlinson, L. A., and Nitsch, D., “Chronic kidney disease and cause-specific hospitalisation: a matched cohort study using primary and secondary care patient data”, Br J Gen Pract, vol. 68, pp. e512-e523, 2018.

S. J. Sinnott, Smeeth, L., Williamson, E., Perel, P., Nitsch, D., Tomlinson, L. A., and Douglas, I. J., “The comparative effectiveness of fourth-line drugs in resistant hypertension: An application in electronic health record data”, Pharmacoepidemiol Drug Saf, 2019.

S. Wilkinson, Williamson, E., Pokrajac, A., Fogarty, D., Stirnadel-Farrant, H., Smeeth, L., Douglas, I. J., and Tomlinson, L. A., “Comparative effects of sulfonylureas, DPP4is and SGLT2 inhibitors added to metformin monotherapy: a propensity-score matched cohort study in UK primary care”, Diabetes Obes Metab, 2020.

P. Bidulka, Iwagami, M., Mansfield, K. E., Kalogirou, F., Wong, A. Y. S., Douglas, I. J., Smeeth, L., Summers, C., and Tomlinson, L. A., “Comparisons of Staphylococcus aureus infection and other outcomes between users of angiotensin-converting-enzyme inhibitors and angiotensin II receptor blockers: lessons for COVID-19 from a nationwide cohort study”, Wellcome Open Res, vol. 5, p. 77, 2020.

E

G. H. B. Greenhall, Mansfield, K. E., Nitsch, D., Iwagami, M., Leyrat, C., Johnston, R., Smeeth, L., and Tomlinson, L. A., “The effect of initiation of renin-angiotensin system inhibitors on haemoglobin: A national cohort study”, Br J Clin Pharmacol, 2020.

F

S. Wilkinson, Douglas, I. J., Williamson, E., Stirnadel-Farrant, H. A., Fogarty, D., Pokrajac, A., Smeeth, L., and Tomlinson, L. A., “Factors associated with choice of intensification treatment for type 2 diabetes after metformin monotherapy: a cohort study in UK primary care”, Clin Epidemiol, vol. 10, pp. 1639-1648, 2018.

G

M. Iwagami, Tomlinson, L. A., Mansfield, K. E., Douglas, I. J., Smeeth, L., and Nitsch, D., “Gastrointestinal bleeding risk of selective serotonin reuptake inhibitors by level of kidney function: A population-based cohort study”, Br J Clin Pharmacol, vol. 84, pp. 2142-2151, 2018.

L

T. A. Yates, Tomlinson, L. A., Bhaskaran, K., Langan, S., Thomas, S., Smeeth, L., and Douglas, I. J., “Lansoprazole use and tuberculosis incidence in the United Kingdom Clinical Practice Research Datalink: A population based cohort”, PLoS Med, vol. 14, p. e1002457, 2017.

P

K. E. Mansfield, Nitsch, D., Smeeth, L., Bhaskaran, K., and Tomlinson, L. A., “Prescription of renin-angiotensin system blockers and risk of acute kidney injury: a population-based cohort study”, BMJ Open, vol. 6, p. e012690, 2016.

M. Iwagami, Tomlinson, L. A., Mansfield, K. E., McDonald, H. I., Smeeth, L., and Nitsch, D., “Prevalence, incidence, indication, and choice of antidepressants in patients with and without chronic kidney disease: a matched cohort study in UK Clinical Practice Research Datalink”, Pharmacoepidemiol Drug Saf, vol. 26, pp. 792-801, 2017.

J. P. Brown, Tazare, J. R., Williamson, E., Mansfield, K. E., Evans, S. J., Tomlinson, L. A., Bhaskaran, K., Smeeth, L., Wing, K., and Douglas, I. J., “Proton pump inhibitors and risk of all-cause and cause-specific mortality: a cohort study”, Br J Clin Pharmacol, 2021.

S

M. Schmidt, Mansfield, K. E., Bhaskaran, K., Nitsch, D., Sorensen, H. T., Smeeth, L., and Tomlinson, L. A., “Serum creatinine elevation after renin-angiotensin system blockade and long term cardiorenal risks: cohort study”, Bmj, vol. 356, p. j791, 2017.

M. Iwagami, Mansfield, K. E., Hayes, J. F., Walters, K., Osborn, D. P., Smeeth, L., Nitsch, D., and Tomlinson, L. A., “Severe mental illness and chronic kidney disease: a cross-sectional study in the United Kingdom”, Clin Epidemiol, vol. 10, pp. 421-429, 2018.

P. Bidulka, Fu, E. L., Leyrat, C., Kalogirou, F., McAllister, K. S. L., Kingdon, E. J., Mansfield, K. E., Iwagami, M., Smeeth, L., Clase, C. M., Bhaskaran, K., van Diepen, M., Carrero, J. J., Nitsch, D., and Tomlinson, L. A., “Stopping renin-angiotensin system blockers after acute kidney injury and risk of adverse outcomes: parallel population-based cohort studies in English and Swedish routine care”, BMC Med, vol. 18, p. 195, 2020.

T

E. Crellin, Mansfield, K. E., Leyrat, C., Nitsch, D., Douglas, I. J., Root, A., Williamson, E., Smeeth, L., and Tomlinson, L. A., “Trimethoprim use for urinary tract infection and risk of adverse outcomes in older patients: cohort study”, Bmj, vol. 360, p. k341, 2018.

V

M. Iwagami, Tomlinson, L. A., Mansfield, K. E., Casula, A., Caskey, F. J., Aitken, G., Fraser, S. D. S., Roderick, P. J., and Nitsch, D., “Validity of estimated prevalence of decreased kidney function and renal replacement therapy from primary care electronic health records compared with national survey and registry data in the United Kingdom”, Nephrol Dial Transplant, vol. 32, pp. ii142-ii150, 2017.

[Page last reviewed 6 April 2021]